Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Finished Drug Prices
NA
1. 156-s
2. 2-(4-((2-oxocyclopentyl)methyl)phenyl)propionic Acid
3. 2-ocppp
4. Cs 600
5. Cs-600
6. Loxoprofen
7. Loxoprofen Alcohol
8. Loxoprofen Sodium, (r*,s*)-isomer
9. Sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate Dihydrate
10. Sodium Loxoprofen
1. 226721-96-6
2. Loxonin
3. Oxeno
4. Lobu
5. Loxoprofen Sodium
6. Loxoprofen Sodium Hydrate
7. Loxoprofen Sodium Salt Dihydrate
8. 80382-23-6
9. Loxoprofen Sodium [mart.]
10. Loxoprofen Sodium Hydrate [jp]
11. Loxoprofen (monosodium)
12. Lobu; Loxonin;cs 600
13. Sodium;2-[4-[(2-oxocyclopentyl)methyl]phenyl]propanoate;dihydrate
14. Z2dr42l11y
15. Monosodium 2-(4-((2-oxocyclopentyl)methyl)phenyl)propanoate Dihydrate
16. Sodium 2-(4-(2-oxocyclopentylmethyl)phenyl)propionate Dihydrate
17. Alpha-methyl-4-((2-oxocyclopentyl)methyl)benzeneacetate Sodium Salt Dihydrate
18. Unii-z2dr42l11y
19. Lorfenamin (tn)
20. Loxonin (tn)
21. Loxoprofensodiumdihydrate
22. Chebi:31786
23. Dtxsid601001203
24. Loxoprofen Sodium Hydrate (jp17)
25. Bja72196
26. Ac-555
27. Mfcd01745788
28. Akos015894920
29. Akos015963323
30. Benzeneacetic Acid, Alpha-methyl-4-((2-oxocyclopentyl)methyl)-, Sodium Salt, Hydrate (1:1:2)
31. (r)-2-chloro-3-methylbutyricacid
32. As-82727
33. Loxoprofen Sodium Dihydrate [who-dd]
34. D01709
35. Q27114685
36. Sodium 2-[4-(2-oxocyclopentylmethyl) Phenyl]-propionate Dihydrate
37. Sodium 2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoate--water (1/1/2)
38. Sodium 2-{4-[(2-oxocyclopentyl)methyl]phenyl}propanoate--water (1/2)
39. Benzeneacetic Acid, .alpha.-methyl-4-((2-oxocyclopentyl)methyl)-, Sodium Salt, Hydrate (1:1:2)
Molecular Weight | 304.31 g/mol |
---|---|
Molecular Formula | C15H21NaO5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 304.12866805 g/mol |
Monoisotopic Mass | 304.12866805 g/mol |
Topological Polar Surface Area | 59.2 âв |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 321 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 225
2019 Revenue in Millions : 265
Growth (%) : -15
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 192
2020 Revenue in Millions : 224
Growth (%) : -8
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2022 Revenue in Millions : 148
2021 Revenue in Millions : 192
Growth (%) : -23
Main Therapeutic Indication : Musculoskeletal
Currency : USD
2023 Revenue in Millions : 111
2022 Revenue in Millions : 148
Growth (%) : -16
Main Therapeutic Indication : Anti-inflammatory
Currency : USD
2017 Revenue in Millions : 376
2016 Revenue in Millions : 356
Growth (%) : 6
Main Therapeutic Indication : Anti-Inflammatory
Currency : USD
2018 Revenue in Millions : 286
2017 Revenue in Millions : 353
Growth (%) : -19%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 269
2018 Revenue in Millions : 296
Growth (%) : -9
Market Place
Reply
12 Jul 2023
Reply
10 Jun 2022
Reply
09 Oct 2021
Reply
19 Oct 2020
Reply
23 May 2019
Reply
09 Oct 2018
Reply
20 Jul 2018
Reply
14 Jul 2018
Reply
07 May 2018
Reply
07 Jun 2017
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?